The Discounted Cash Flow (DCF) valuation of Haemonetics Corp (HAE) is 106.03 USD. With the latest stock price at 76.87 USD, the upside of Haemonetics Corp based on DCF is 37.9%.
Based on the latest price of 76.87 USD and our DCF valuation, Haemonetics Corp (HAE) is a buy. buying HAE stocks now will result in a potential gain of 37.9%.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 8.0% | 7.2% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 70.93 - 195.86 | 106.03 |
| Upside | -7.7% - 154.8% | 37.9% |